Bond Screener
ANI Pharmaceuticals
LEI 5493000T6CXTND40YH31
Organization name
ANI Pharmaceuticals, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
316 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
ANI Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals. The company manufactures oral solid dose products, as well as liquids and topicals, narcotics, and potent products; and Lithobid lithium carbonate extended release tablets. Its targeted areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products.
|
General information
-
Organization nameANI Pharmaceuticals, Inc.
-
Organization statusOperating organization
-
AddressCorporation Trust Center 1209 Orange St, Wilmington, USA, 19801
-
Site
News
-
ANI Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Exhibits19/08/2026
-
ANIP Stock: Insider Selling & Clinical Trial Success15/07/2026
-
ANI Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Exhibits21/05/2026
-
ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Shows Strong Financial Health Amidst Insider and Institutional Sales14/05/2026
-
ANI Pharmaceuticals: Changes In Registrant’s Certifying Accountant, Exhibits01/04/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameANI Pharmaceuticals, Inc.
-
Organization statusOperating organization
-
AddressCorporation Trust Center 1209 Orange St, Wilmington, USA, 19801
-
Site
Codes
-
LEI5493000T6CXTND40YH31
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001023024
-
EIN58-2301143
